FILE – In this Aug. 14, 2018 file photo, Dr. William Burke goes over a PET brain scan at Banner Alzheimers Institute in Phoenix. The drug company Biogen Inc. says it will seek federal approval for a ...
It’s estimated that around 944,000 people in the UK are living with dementia, a number expected to rise to one million by 2030 and 1.4 million by 2040. The syndrome, which is currently the leading ...
MedPage Today on MSN
Benzodiazepines, Antipsychotics Raise Mortality Risk for Some Dementia Patients
Newly prescribed benzodiazepines or antipsychotics were tied to higher mortality for dementia patients in hospice. The drugs ...
After witnessing my mum's cognitive decline and with dementia now the leading cause of death for Australian women, I can't help but wonder: Will I be among them? I started noticing changes when my mum ...
Medications commonly prescribed to ease dementia symptoms such as agitation, anxiety, and delirium — benzodiazepines and antipsychotics — may carry major unintended risks for people with dementia ...
Earlier this year, two new drugs that have been shown in global trials to slow early-stage Alzheimer's disease, donanemab and lecanemab, were rejected by the Scottish Medicines Consortium (SMC), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback